U.S. Clinical Laboratory Tests Market Size to Grow at a CAGR of 5.3% During 2020-2025 The Growing Rate of Insufficient Exercise, Consumption of Unhealthy Food, and the Subsequent Rise in Cases of Obesity Which are Contributing to the Growth of U.S. Clinical Laboratory Tests Market.
BriefingWire.com, 3/03/2021 - U.S. Clinical Laboratory Tests Market size in 2019 is estimated to be $6,000 million, growing at a CAGR of 5.3% during the forecast period 2020-2025. Clinical laboratory tests is a group of medical tests carried out in a laboratory equipped with all aspects of laboratory medicine and instruments. These tests are performed on clinical specimen to obtain information about the health of patients, and Diagnosis & treatment of their respective condition. Increasing prevalence of Chronic diseases and technological advancement are the major factors driving the growth of the market. Moreover, rising geriatric population and advancement of R&D activiti
Global $1 8 Billion Rare Disease Genetic Testing Market to 2027: Focused Approach of Key Market Players on Cost-Effective Treatments are Driving Growth
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global $1 8 Billion Rare Disease Genetic Testing Market to 2027: Focused Approach of Key Market Players on Cost-Effective Treatments are Driving Growth
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global drug discovery outsourcing market size is expected to reach USD 5.4 billion by 2028 registering a CAGR of 7.4% over the forecast period.
Drug discovery is a costly and lengthy process. This has forced pharmaceutical and biotech companies to opt for outsourcing their research activities to academic and private Contract Research Organizations (CROs). Thus, factors such as high R&D costs, patent expiration of best-selling drugs, and the need to speed up the drug discovery process, are expected to boost the demand for outsourcing of drug discovery in the coming years.
Rising cases of chronic diseases have compelled companies to develop better medicines. Some of the key therapeutic areas where companies are actively involved in outsourcing include oncology, cardiovascular, and anti-infectives. In November 2020, AstraZeneca collaborated with 9 of the foremost oncology medical centers to expedite rese